Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells
IntroductionTriple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by high metastatic potential and limited targeted therapeutic options.